As antibiotic resistance is growing and posing a threat on public health, developing new antibiotics has become more urgent than ever. Researchers have recently revealed the virulence regulatory mechanism in Pseudomonas aeruginosa, a superbug which is common in patients with a weak immune system and is resistant to many antibiotics. The findings pave ways for identifying good antibiotic targets for new drug development.